Recursion Pharmaceuticals (RXRX) Capital Expenditures (2020 - 2026)
Recursion Pharmaceuticals (RXRX) posted Capital Expenditures of $44,000 for Q2 2026, down 98.6% from $3.15 million a year earlier and down 82.9% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Capital Expenditures (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Recursion Pharmaceuticals was $1.79 million, down 83.5% year-over-year; for FY2025, it came in at $6.47 million, down 52.8% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- In prior years, Recursion Pharmaceuticals' Capital Expenditures was $13.7 million in FY2024 (+14.6%), $11.96 million in FY2023 (-67.7%), $37.06 million in FY2022 (-6.9%) and $39.8 million in FY2021 (+582.5%).
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures in data going back to Q1 2020.
- On a year-over-year basis, Capital Expenditures has declined in each of the last four quarters, with growth averaging 35.7% over the last eight quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2024, with growth of 512.3%; the weakest was Q2 2026, with a decline of 98.6%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $258,000 (Q1 2026), $1.24 million (Q4 2025) and $243,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Recursion Pharmaceuticals | 1.98 Bn | -627.04 Mn | -3.82 Mn | 44,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44,000.00 |
| Mar 31, 2026 | 258,000.00 |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 1.83 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 4.56 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 6.65 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 745,000.00 |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 5.18 Mn |
| Dec 31, 2022 | 7.98 Mn |
| Sep 30, 2022 | 8.26 Mn |
| Jun 30, 2022 | 16.48 Mn |
| Mar 31, 2022 | 4.34 Mn |
| Dec 31, 2021 | 4.46 Mn |
| Sep 30, 2021 | 9.71 Mn |
API Access
Recursion Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();